Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
16,25 CHF | +0,93 % | -1,22 % | -33,67 % |
26.07. | Bellevue Group AG meldet Ergebnis für das Halbjahr per 30. Juni 2024 | CI |
25.07. | Bellevue Group verzeichnet niedrigeren Gewinn und Umsatz im ersten Halbjahr | MT |
Bellevue Group AG Gruppe: Beziehungs-Chart
Private Unternehmen, die zur gleichen Gruppe wie BELLEVUE GROUP AG gehören
Unternehmen | Geschäftsführender Direktor |
---|---|
Asset Management BAB NV | - |
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is an asset management firm headquartered in Küsnacht, Switzerland. The firm was founded in 1993 and is a wholly-owned subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on the global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Gebhard Giselbrecht |
Bellevue Private Markets AG | Jan Kollros |
MarketScreener is also available in this country: United States.
Switch edition